All In Biotech

Free tool

FAERS Monitor: Enbrel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103795 or its brand name (Enbrel, Etanercept). Reports on generic versions are filed under their own applications.

Reports

597,166

Serious

216,189

36% of reports

Hospitalization

66,992

Death reported

17,505

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective75,667
  • injection site pain56,857
  • rheumatoid arthritis47,136
  • arthralgia45,566
  • pain43,715
  • injection site erythema41,077
  • fatigue30,777
  • joint swelling25,864
  • pain in extremity25,734
  • psoriasis25,160
  • headache25,036
  • injection site swelling23,301
  • off label use22,780
  • injection site pruritus22,130
  • injection site reaction20,969

Reports by year received

View as table
YearReports
20041,194
20051,836
20068,806
200717,520
200816,649
200914,437
201022,274
201129,182
201242,296
201346,953
201441,070
201557,540
201658,757
201759,690
201849,137
201930,610
202026,238
202117,083
202217,132
202313,528
202411,931
20257,857
20265,446

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,456,993 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal47,13624.324.0619,026
injection site erythemaSignal41,07716.916.7414,581
injection site pruritusSignal22,13016.916.6222,129
injection site reactionSignal20,96915.014.8191,094
injection site swellingSignal23,30114.914.7211,903
joint swellingSignal25,8649.39.2152,040
psoriasisSignal25,1608.28.1128,513
injection site painSignal56,8577.87.7278,010
arthralgiaSignal45,5664.24.2101,373
pain in extremitySignal25,7343.33.237,637
painSignal43,7152.62.641,963
drug ineffectiveSignal75,6672.12.142,927
headache25,0361.41.43,119
fatigue30,7771.41.43,636
off label use22,7800.90.9187

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.